These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 19473900)
1. [Hyperprolactinemia in a child diagnosed with Asperger syndrome and hyperkinetic disorder treated with risperidone]. Monge Galindo L; Escosa García L; García Sánchez N; Ruiz-Lázaro PM An Pediatr (Barc); 2009 Jul; 71(1):86-7. PubMed ID: 19473900 [No Abstract] [Full Text] [Related]
2. Risperidone-induced sexual dysfunction in a prepubertal child - a case report. Wadoo O; Chalhoub N J Psychopharmacol; 2009 Aug; 23(6):727-8. PubMed ID: 18562402 [TBL] [Abstract][Full Text] [Related]
3. Risperidone and withdrawal dyskinesia. Lore C J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):941. PubMed ID: 10939219 [No Abstract] [Full Text] [Related]
4. Case report: valproic Acid and risperidone treatment leading to development of hyperammonemia and mania. Carlson T; Reynolds CA; Caplan R J Am Acad Child Adolesc Psychiatry; 2007 Mar; 46(3):356-361. PubMed ID: 17314721 [TBL] [Abstract][Full Text] [Related]
5. Risperidone and tardive dyskinesia. Feeney DJ; Klykylo W J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421-2. PubMed ID: 8936904 [No Abstract] [Full Text] [Related]
6. Efficacy of risperidone treatment in Smith-Magenis syndrome (del 17 pll. 2). Niederhofer H Psychiatr Danub; 2007 Sep; 19(3):189-92. PubMed ID: 17914318 [TBL] [Abstract][Full Text] [Related]
7. A washout period needed before switching from a neuroleptic to an amphetamine. Prescrire Int; 2009 Aug; 18(102):165. PubMed ID: 19743579 [TBL] [Abstract][Full Text] [Related]
12. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients]. Konarzewska B; Szulc A; Popławska R; Galińska B; Juchnowicz D Psychiatr Pol; 2008; 42(1):87-95. PubMed ID: 18567406 [TBL] [Abstract][Full Text] [Related]
13. Granulomatous cutaneous lesions associated with risperidone-induced hyperprolactinemia in an amputated upper limb. Lin CH; Ma H; Chung MT; Chou J Int J Dermatol; 2012 Jan; 51(1):75-8. PubMed ID: 21834946 [No Abstract] [Full Text] [Related]
14. Risperidone in children with autism and serious behavioral problems. Valiquette G N Engl J Med; 2002 Dec; 347(23):1890-1; author reply 1890-1. PubMed ID: 12472071 [No Abstract] [Full Text] [Related]
15. Oxyprothepin and clorotepin compared in the hyperkinetic syndrome. Výborová L; Náhunek K; Drtilková I; Balastíková B Act Nerv Super (Praha); 1989 Apr; 31(1):45-6. PubMed ID: 2571227 [No Abstract] [Full Text] [Related]
16. [Hyperprolactinemia induced by neuroleptics]. Lakartidningen; 2007 May 9-15; 104(19):1522. PubMed ID: 17550031 [No Abstract] [Full Text] [Related]
17. Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection. Bai YM; Chen TT; Lin WK; Chang WH; Wu B; Hung CH; Chou P; Chen JY J Clin Psychopharmacol; 2007 Jun; 27(3):306-8. PubMed ID: 17502783 [No Abstract] [Full Text] [Related]
18. A case of antipsychotic-induced hyperglycemia in a child with insulin dependent diabetes mellitus. Stern AP; Trieu ML J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):403-4. PubMed ID: 23083030 [No Abstract] [Full Text] [Related]
19. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia. Kopecek M; Bares M; Horacek J; Mohr P Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006 [TBL] [Abstract][Full Text] [Related]